pharmacies must stop selling compounded semaglutide A South African court has ordered pharmacy group iDexis to semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company FDA restricts non-approved compounded GLP-1

You dont see muscle loss on a bathroom scale

Newer medicine options, including the sodium-glucose cotransport 2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, have been shown to protect the heart and reduce the risk of many specific heart-related outcomes for people with type 2 diabetes

The regulator said it remained concerned that some practitioners working in health services designed to provide customers with access to a predetermined medicine may be failing to meet the standards of good practice

If a pair of allosteric effectors of metabolites and the responsible metabolic enzyme has more than one K i value among three species, we calculated the geometric mean of the K i values and used it as the K i value for that paired regulation